Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate
- 6 October 2015
- journal article
- case report
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 8 (6) , 414-420
Abstract
A 68-year-old man was referred to our hospital because of left upper quadrant pain. Contrast enhanced computed tomography showed a low density mass with delayed contrast effects as well as para-aortic node swelling with homogenous contrast effects. Histological examination of specimens obtained by endoscopic ultrasound fine needle aspiration revealed a pancreatic neuroendocrine tumor (NET) G2, according to the World Health Organization 2010 classification, and lymph node metastasis. Distal pancreatectomy and lymph node dissection were performed. On histological examination, the tumor showed well-differentiated morphology with an organoid pattern. The Ki67 labeling index was 21.6 %, and the mitotic count was 25/10 high power fields. As mentioned above, we made a final diagnosis of the lesion as “NET G3,” because the tumor presented with well-differentiated morphology. Chemotherapy with Everolimus was administered. Liver metastasis occurred 11 months after the first operation, and a partial hepatectomy was performed. Histological findings were similar to those of the first operation. Herein we present a case of pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate referred to as “NET G3,” and review the relevant literature.Keywords
This publication has 27 references indexed in Scilit:
- Are G3 ENETS neuroendocrine neoplasms heterogeneous?Endocrine-Related Cancer, 2013
- Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC studyAnnals of Oncology, 2012
- Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective studyGastrointestinal Endoscopy, 2012
- Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine TumorsAmerican Journal of Surgical Pathology, 2012
- Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the LiverAmerican Journal of Surgical Pathology, 2011
- Survival and Prognostic Factor Analysis in Patients With Metastatic Pancreatic Endocrine CarcinomasPancreas, 2009
- Proliferative rate in endoscopic ultrasound fine‐needle aspiration of pancreatic endocrine tumorsCancer Cytopathology, 2009
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic StratificationNeuroendocrinology, 2008
- Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumorsCancer, 2008
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006